Noble

Executive Summary

Noble is a digital health company specializing in patient training and engagement solutions for drug delivery systems. Founded in 2017 and headquartered in New York, the company combines physical training devices with digital support to improve patient confidence, adherence, and real-world outcomes. Noble's services span UX design and human factors research for device development, clinical training enablement, and post-launch patient support programs. By addressing the critical gap between drug delivery device design and patient use, Noble aims to reduce medication errors and enhance therapeutic efficacy for pharmaceutical partners. The company operates at the intersection of digital health and AI/machine learning, leveraging technology to personalize training and support. Although privately held with limited public financial information, Noble's focus on a high-need area within healthcare—patient adherence—positions it as a potential partner for biopharma companies seeking to improve real-world outcomes for their injectable and self-administered therapies.

Upcoming Catalysts (preview)

• Q4 2026Strategic Partnership with Major Pharmaceutical Company65% success
• Q2 2026Launch of AI-Powered Digital Training Platform70% success
• Q3 2026FDA Clearance for Novel Training Device50% success